Fucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia, in vitro and in vivo

The morbidity and mortality associated with current therapies for acute promyelocytic leukemia (APL) remain a significant clinical concern, despite improvements in patient survival. Consequently, the development of adjuvant therapies that increase efficacy while reducing morbidities is important. Re...

Descripción completa

Detalles Bibliográficos
Autores principales: Atashrazm, Farzaneh, Lowenthal, Ray M., Dickinson, Joanne L., Holloway, Adele F., Woods, Gregory M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216779/
https://www.ncbi.nlm.nih.gov/pubmed/27329592
http://dx.doi.org/10.18632/oncotarget.10016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216779/
https://www.ncbi.nlm.nih.gov/pubmed/27329592
http://dx.doi.org/10.18632/oncotarget.10016

Ejemplares similares